BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29385279)

  • 1. Chronic lymphoproliferative disorder of NK-cells: A single-institution review with emphasis on relative utility of multimodality diagnostic tools.
    Kurt H; Jorgensen JL; Amin HM; Patel KP; Wang SA; Lin P; Kanagal-Shamanna R; Loghavi S; Thakral B; Khogeer HA; Jabbour EJ; Li S; Yin CC; Medeiros LJ; Khoury JD
    Eur J Haematol; 2018 May; 100(5):444-454. PubMed ID: 29385279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
    Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
    Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic profile of expanded NK cells in chronic lymphoproliferative disorders: a surrogate marker for NK-cell clonality.
    Bárcena P; Jara-Acevedo M; Tabernero MD; López A; Sánchez ML; García-Montero AC; Muñoz-García N; Vidriales MB; Paiva A; Lecrevisse Q; Lima M; Langerak AW; Böttcher S; van Dongen JJ; Orfao A; Almeida J
    Oncotarget; 2015 Dec; 6(40):42938-51. PubMed ID: 26556869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis.
    Li Y; Wei J; Mao X; Gao Q; Liu L; Cheng P; Liu L; Zhang X; Zhang K; Wang J; Zhu L; Zhou J; Zhang Y; Meng L; Sun H; Li D; Huang M; Huang W; Deng J; Zhang D
    PLoS One; 2016; 11(8):e0158827. PubMed ID: 27483437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary infiltration as the initial manifestation of chronic lymphoproliferative disorder of natural killer cells: a case report and literature review.
    Zhang J; Wang P; Yan X
    BMC Pulm Med; 2021 Mar; 21(1):94. PubMed ID: 33740949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis.
    Lima M; Almeida J; Montero AG; Teixeira Mdos A; Queirós ML; Santos AH; Balanzategui A; Estevinho A; Algueró Mdel C; Barcena P; Fonseca S; Amorim ML; Cabeda JM; Pinho L; Gonzalez M; San Miguel J; Justiça B; Orfão A
    Am J Pathol; 2004 Oct; 165(4):1117-27. PubMed ID: 15466379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of flow cytometry in differentiating NK/T cell lymphoma from indolent and reactive NK cell proliferations.
    de Mel S; Li JB; Abid MB; Tang T; Tay HM; Ting WC; Poon LM; Chung TH; Mow B; Tso A; Ong KH; Chng WJ; Liu TC
    Cytometry B Clin Cytom; 2018 Jan; 94(1):159-168. PubMed ID: 28431200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3 mutations in natural killer cells are associated with cytopenia in patients with chronic lymphoproliferative disorder of natural killer cells.
    Kawakami T; Sekiguchi N; Kobayashi J; Yamane T; Nishina S; Sakai H; Hirabayashi Y; Nakazawa H; Ishida F
    Int J Hematol; 2019 May; 109(5):563-571. PubMed ID: 30859397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia.
    Jerez A; Clemente MJ; Makishima H; Koskela H; Leblanc F; Peng Ng K; Olson T; Przychodzen B; Afable M; Gomez-Segui I; Guinta K; Durkin L; Hsi ED; McGraw K; Zhang D; Wlodarski MW; Porkka K; Sekeres MA; List A; Mustjoki S; Loughran TP; Maciejewski JP
    Blood; 2012 Oct; 120(15):3048-57. PubMed ID: 22859607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive mature natural killer cell neoplasms: report on a series of 12 European patients with emphasis on flow cytometry based immunophenotype and DNA content of neoplastic natural killer cells.
    Lima M; Spínola A; Fonseca S; Santos AH; Rodrigues J; Oliveira L; Queirós ML; Santos M; Gonçalves M; Lau C; Teixeira Mdos A; Gonçalves C; Marques C; Guerreiro M; Cunha M; Príncipe F; Coutinho J
    Leuk Lymphoma; 2015 Jan; 56(1):103-12. PubMed ID: 24669939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Large Granular Lymphocytic Leukemia and JAK/STAT Signaling Pathway--Review].
    Qiu ZY; Fan Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):254-60. PubMed ID: 26913432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation.
    Barilà G; Teramo A; Calabretto G; Ercolin C; Boscaro E; Trimarco V; Carraro S; Leoncin M; Vicenzetto C; Cabrelle A; Facco M; Piazza F; Semenzato G; Zambello R
    Blood Cancer J; 2018 Jun; 8(6):51. PubMed ID: 29891951
    [No Abstract]   [Full Text] [Related]  

  • 13. Genomic landscape of T-large granular lymphocyte leukemia and chronic lymphoproliferative disorder of NK cells: a single institution experience.
    Fei F; Stehr H; Zehnder JL
    Leuk Lymphoma; 2023 Sep; 64(9):1536-1544. PubMed ID: 37330635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells.
    Pastoret C; Desmots F; Drillet G; Le Gallou S; Boulland ML; Thannberger A; Doncker AV; Salaun V; Damaj GL; Veyrat-Masson R; Tournilhac O; Moignet A; Pangault C; Roussel M; Fest T; Lamy T
    Blood; 2021 Jun; 137(23):3237-3250. PubMed ID: 33512451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients.
    Poullot E; Zambello R; Leblanc F; Bareau B; De March E; Roussel M; Boulland ML; Houot R; Renault A; Fest T; Semenzato G; Loughran T; Lamy T
    Ann Oncol; 2014 Oct; 25(10):2030-2035. PubMed ID: 25096606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological and phenotypic features of chronic NK cell lymphocytosis identified among patients with asymptomatic lymphocytosis.
    Cao F; Zhao H; Li Y; Dai S; Wang C
    Int J Lab Hematol; 2015 Dec; 37(6):783-90. PubMed ID: 26234181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed-phenotype large granular lymphocytic leukemia: a rare subtype in the large granular lymphocytic leukemia spectrum.
    Neff JL; Rangan A; Jevremovic D; Nguyen PL; Chiu A; Go RS; Chen D; Morice WG; Shi M
    Hum Pathol; 2018 Nov; 81():96-104. PubMed ID: 29949739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high definition picture of somatic mutations in chronic lymphoproliferative disorder of natural killer cells.
    Gasparini VR; Binatti A; Coppe A; Teramo A; Vicenzetto C; Calabretto G; Barilà G; Barizza A; Giussani E; Facco M; Mustjoki S; Semenzato G; Zambello R; Bortoluzzi S
    Blood Cancer J; 2020 Apr; 10(4):42. PubMed ID: 32321919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Large granular lymphocytic leukemia CD3
    Cupaiolo R; Cherifi S; Lelubre C; Govaerts D; Delefortrie Q; Corazza F; Chevalier C
    Ann Biol Clin (Paris); 2018 Aug; 76(4):429-434. PubMed ID: 30078779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic T-cell lymphoproliferative disease expressing natural killer cell receptors: clinicopathological and molecular features.
    Kwong YL; Lam CC; Choy C; Man C; Au WY; Siu LL
    Cancer Genet Cytogenet; 2001 Sep; 129(2):168-72. PubMed ID: 11566350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.